Description

Thymosin products which can enhance body immunity are mainly used in the treatment of hepatitis and tumor and can be categorized into thymosin (extracted), thymopentin and thymosin α1, a high-end product.

First developed by SciClone Pharmaceuticals, Inc., thymosin α1’s being used for tumor immunotherapy as immunomodulator has increasingly gained people’s attention. In the clinic, it has been used for the treatment of many kinds of tumors like non-small cell lung cancer, malignant melanoma, liver cancer, non-Hodgkin lymphomia and so on. Research has shown that thymosin α1 can enhance patients’ immunity, reduce side effects and infection rate, improve life quality and raise remission rate or even survival rate in the chemotherapy for tumors. As a vaccine adjuvant, thymosin α1 can boost the immune response to viral vaccines like influenza vaccine and hepatitis B vaccine in patients whose immune systems are comprised or inhibited, patients with chronic hemodialysis or senile diseases included.

View Full Report at: http://www.marketresearchreports.biz/analysis/294404

Thymosin α1 develops fast after entering China, annual sales value rising from less than CNY 7 million in 2005 to CNY 968 million in 2014 and CAGR reaching up to 73.7%. currently, thymosin α1 in the Chinese market mainly come from Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia has the largest market share of nearly 50% for sales volume in 2014.

In the next few years, the market size of immunomodulator will grow gradually, so does that of thymosin α1.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/294404

Readers can get at least the following information from this report:

market size of thymosin α1 in China
competitive landscape of thymosin α1 in Chinese market
price of thymosin α1 made by different enterprises in China
market outlook of thymosin α1 in China
The author suggests the following groups of people purchase this report:

manufacturers of immunomodulator
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Thymosin α1
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Thymosin α1 in China
2.1 Patent and Approval Status of Thymosin α1 in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Thymosin α1 in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]